We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12B
AUM Growth
-$882M
Cap. Flow
-$307M
Cap. Flow %
-2.56%
Top 10 Hldgs %
23.8%
Holding
2,895
New
41
Increased
683
Reduced
1,007
Closed
96

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 13.65%
3 Financials 12.21%
4 Consumer Discretionary 10.98%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VUZI icon
2351
Vuzix
VUZI
$219M
$184K ﹤0.01%
31,766
+4,344
+16% +$33.5K
SCCO icon
2352
Southern Copper
SCCO
$159B
$183K ﹤0.01%
4,461
-14
-0.3% -$612
CFLT
2353
DELISTED
Confluent
CFLT
$183K ﹤0.01%
7,705
+5
+0.1% +$135
TARS icon
2354
Tarsus Pharmaceuticals
TARS
$3.01B
$183K ﹤0.01%
10,674
ARCT icon
2355
Arcturus Therapeutics
ARCT
$223M
$183K ﹤0.01%
12,327
GPMT
2356
Granite Point Mortgage Trust
GPMT
$59.3M
$183K ﹤0.01%
28,345
FEAM icon
2357
5E Advanced Materials
FEAM
$66.4M
$182K ﹤0.01%
781
HIFS icon
2358
Hingham Institution for Saving
HIFS
$695M
$182K ﹤0.01%
726
KALV
2359
DELISTED
KalVista Pharmaceuticals
KALV
$181K ﹤0.01%
12,495
HLTH
2360
DELISTED
Cue Health Inc. Common Stock
HLTH
$181K ﹤0.01%
60,168
ONEW icon
2361
OneWater Marine
ONEW
$203M
$181K ﹤0.01%
6,012
ACET icon
2362
Adicet Bio
ACET
$77.3M
$181K ﹤0.01%
795
STEL
2363
DELISTED
Stellar Bancorp
STEL
$181K ﹤0.01%
6,171
-3,396
-35% -$102K
GOEV
2364
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$180K ﹤0.01%
209
+131
+168% +$191K
INBK icon
2365
First Internet Bancorp
INBK
$255M
$180K ﹤0.01%
5,314
RUSHB icon
2366
Rush Enterprises Class B
RUSHB
$9.34B
$180K ﹤0.01%
5,624
ATRA icon
2367
Atara Biotherapeutics
ATRA
$77.7M
$179K ﹤0.01%
1,892
+208
+12% +$23.4K
PFHD
2368
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$178K ﹤0.01%
6,880
MCS icon
2369
Marcus Corp
MCS
$918M
$178K ﹤0.01%
12,824
ICPT
2370
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$178K ﹤0.01%
12,747
-3,729
-23% -$60K
BV icon
2371
BrightView Holdings
BV
$1.09B
$178K ﹤0.01%
22,371
MDXG icon
2372
MiMedx Group
MDXG
$614M
$178K ﹤0.01%
61,863
+7,298
+13% +$25.9K
RMAX icon
2373
RE/MAX Holdings
RMAX
$266M
$177K ﹤0.01%
9,368
MIRM icon
2374
Mirum Pharmaceuticals
MIRM
$6.05B
$177K ﹤0.01%
8,428
RMR icon
2375
The RMR Group
RMR
$343M
$177K ﹤0.01%
7,468

Similar funds

MetLife Investment Management's Q3 2022 Portfolio in Review

As of Q3 2022, MetLife Investment Management held 2,895 positions worth $12B, down 6.8% from $12.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. MetLife Investment Management opened 41 new positions and exited 96, leaving the 2,895-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q3 2022 buy was Aspen Technology Inc: 19,662 shares worth $4.68M.
  • MetLife Investment Management added most to iShares MSCI EAFE ETF in Q3 2022, an estimated $24.5M increase.
  • MetLife Investment Management's biggest Q3 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $138M.
  • MetLife Investment Management fully exited SailPoint Technologies Holdings, Inc. Common Stock in Q3 2022, selling an estimated $6.77M.
  • MetLife Investment Management's ten largest holdings make up 24% of its $12B portfolio in Q3 2022.
  • MetLife Investment Management opened 41 new positions and closed 96 in Q3 2022.
  • MetLife Investment Management's portfolio value fell 6.8% quarter-over-quarter to $12B.

Based on MetLife Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.